Incontinence Control Devices — NCD 241 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 241, the National Coverage Determination governing incontinence control devices, effective January 9, 2026. Here's what billing teams need to know.

CMS incontinence control device coverage policy under NCD 241 covers two distinct device categories: mechanical/hydraulic devices and collagen implants. The policy does not list specific CPT or HCPCS codes, but the clinical criteria are detailed and strict — especially for collagen implants, where patient selection, physician qualifications, and treatment limits all affect whether a claim pays or denies. If your practice bills for urinary incontinence procedures under Medicare, review your documentation workflows now, before the January 9, 2026 effective date.

---

Field	Detail
Payer	CMS (Centers for Medicare & Medicaid Services)
Policy	Incontinence Control Devices — NCD 241
Policy Code	NCD 241 Medicare
Change Type	Modified
Effective Date	2026-01-09
Impact Level	High
Specialties Affected	Urology, Gynecology, Physical Medicine & Rehabilitation, Colorectal Surgery
Key Action	Audit patient selection documentation and physician qualification records for collagen implant procedures before January 9, 2026

---

CMS Incontinence Control Device Coverage Criteria and Medical Necessity Requirements 2026

NCD 241 splits coverage into two separate tracks. The rules for each are different enough that your billing team should treat them as two distinct policies.

Mechanical and Hydraulic Devices

CMS covers mechanical/hydraulic incontinence control devices when use is "reasonable and necessary" for the individual patient. These devices control urination by compressing the urethra. Coverage applies to patients with permanent anatomic and neurologic dysfunctions of the bladder.

The medical necessity standard here is relatively straightforward. Document the permanent dysfunction. Document that the device is appropriate for that patient. What you cannot do is bill for temporary conditions or patients who don't meet the permanence threshold — that's a fast path to a claim denial.

Collagen Implants

This is where NCD 241 gets specific, and where most billing risk lives. A collagen implant is classified as a prosthetic device under the Medicare Benefit Category for Prosthetic Devices. Coverage is for stress urinary incontinence caused by intrinsic sphincter deficiency (ISD) only.

Before a patient receives a collagen implant, CMS requires a skin test for collagen sensitivity. The evaluation period is four weeks. Don't skip this — if the documentation doesn't show the skin test and the four-week wait, the claim is exposed.

The pre-treatment evaluation differs by sex. For male patients, CMS requires:

#	Covered Indication Copy
1	A complete history and physical examination
2	A simple cystometrogram confirming the bladder fills and stores properly
3	A standing abdominal stress test (patient upright with a full bladder, coughing or bearing down) — leakage confirms ISD

For female patients, CMS requires:

#	Covered Indication Copy
1	A complete history and physical examination, including a pelvic exam
2	A simple cystometrogram to rule out abnormalities of bladder compliance and urethral support
3	An abdominal leak point pressure (ALLP) test — leakage at less than 100 cm H2O establishes ISD

The ALLP threshold matters for reimbursement. Female patients must have an ALLP of 100 cm H2O or less. If the documentation doesn't capture that measurement with the correct unit (cm H2O) and the bladder fill volume (minimum 150 cc), your claim will not survive a medical necessity review.

Physician qualification is also a coverage requirement. To perform a collagen implant procedure, the physician must have urology training in cystoscope use and must have completed a collagen implant training program. Keep credential records current and accessible. An auditor will ask for them.

There is no prior authorization requirement explicitly stated in NCD 241, but given the clinical specificity of the criteria, your Medicare Administrative Contractor may have supplemental local coverage determination (LCD) requirements. Check with your MAC before billing.

---

CMS Collagen Implant Exclusions and Non-Covered Indications

NCD 241 draws a hard line at treatment failures. Patients who do not improve after five injection procedures across five separate treatment sessions are considered treatment failures. No further collagen implant treatment for urinary incontinence is covered after that point.

This limit applies per course of treatment, not per calendar year. Track session counts carefully in your charge capture system. If a patient hits five sessions without improvement and a provider orders a sixth, that claim will deny. Your billing team should flag this before the claim goes out, not after.

There is one limited exception for recurrence. Patients who responded to collagen implants in the past — typically six to twelve months earlier — may be eligible for additional treatment sessions if the incontinence returns. Coverage of those additional sessions is allowed but requires medical justification. Document the prior successful response, the timeframe, and the clinical basis for resuming treatment. Vague documentation here is a claim denial waiting to happen.

Collagen implants are also not covered for incontinence that does not result from ISD. Urge incontinence, overflow incontinence, and other etiologies are not covered under this policy.

---

Coverage Indications at a Glance

---

CMS Incontinence Control Device Billing Guidelines and Action Items 2026

The January 9, 2026 effective date gives you a narrow window to get documentation and workflows in order. Here's what to do before then.

Copy Action Items

If you're unsure how NCD 241 intersects with your MAC's LCD or your current billing guidelines, talk to your compliance officer before January 9, 2026. The criteria here are specific enough that small documentation gaps turn into real revenue losses.

---

CPT, HCPCS, and ICD-10 Codes for Incontinence Control Devices Under NCD 241

Policy-Specific Codes

The NCD 241 Medicare policy document does not specify CPT, HCPCS Level II, or ICD-10-CM codes. This is not unusual for older NCDs that predate the current code-centric policy format.

This creates a practical problem for billing teams. You are responsible for identifying the correct procedural and diagnosis codes based on the clinical service performed. The policy's coverage criteria — not a code list — determine whether a claim pays.

Work with your coding team or a healthcare billing consultant to map your current code usage to the NCD 241 coverage criteria. Your MAC may list applicable codes in their LCD if one exists for this procedure category.

What to Document in Lieu of a Policy Code List

Since no codes are provided in NCD 241, your claim defense is entirely documentation-based. For every incontinence control device claim under Medicare, your record should answer these questions:

• Which device category — mechanical/hydraulic or collagen implant?
• What is the documented diagnosis and dysfunction type?
• For collagen implants: is ISD established by the required testing protocol?
• What is the patient's sex, and are all sex-specific evaluation steps documented?
• For collagen implants: what session number is this?
• Does the performing physician meet the NCD 241 credential requirements?

If you cannot answer all of these from the medical record, the claim is at risk.

---